DH Bio Co., Ltd.
Quick facts
Phase 3 pipeline
- Haporine-S · Oncology
Haporine-S is a small molecule that targets the PI3K/AKT/mTOR pathway. - Restasis (cyclosporine 0.05%) · Ophthalmology
Restasis works by increasing tear production in patients with dry eye syndrome.
Competitive intelligence
For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:
Frequently asked questions about DH Bio Co., Ltd.
What is DH Bio Co., Ltd.'s pipeline?
DH Bio Co., Ltd. has 2 drugs in Phase 3, 0 in Phase 2, 0 in Phase 1. Late-stage candidates include Haporine-S, Restasis (cyclosporine 0.05%).
Related
- Sector hub: All tracked pharma companies